Myriad Genetics Shares Down 34.3% Since SmarTrend's Sell Call (MYGN)

SmarTrend identified a Downtrend for Myriad Genetics (NASDAQ:MYGN) on October 8th, 2018 at $42.84. In approximately 4 months, Myriad Genetics has returned 34.33% as of today's recent price of...